RNATICS featured in national newspaper

rnatics has been covered in the national newspaper Süddeutsche Zeitung as one of three biotech start-ups in Munich working on RNA therapeutics.

mRNA drugs could be suitable not only as vaccines, but also for treating people who are already ill. Three companies in the southwest of Munich are researching this – and are on the verge of a breakthrough.

Read the full article from the Süddeutsche Zeitung
(nb. article in German)